Skip to main content
. Author manuscript; available in PMC: 2012 May 22.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Aug 10;17(5):664–673. doi: 10.1016/j.bbmt.2010.07.026

Figure 1. Flow of Survey Topics Regarding CMV Disease Prevention after HCT.

Figure 1

CMV- cytomegalovirus, PET- preemptive therapy, ATG- anti-thymocyte globulin, GVHD- graft versus host disease